Key result
Post-STEMI 72-hour NT-proBNP over 830 pg/mL predicts 1-year new-onset heart failure.
Why the study?
The role of NT-proBNP levels measured during hospitalization for STEMI in predicting clinical outcomes, including new-onset heart failure, was not well established.
Cohort (n=72)
Effect estimate: AUC 0.771 (95% CI 0.630-0.912)
p-value: p=0.009
NT-proBNP at 72 h was associated with post-STEMI HF; hypothesis-generating in small cohort and needs prospective validation.
BACKGROUND: Previous studies suggested that N-terminal pro-brain natriuretic peptide (NT-proBNP) level is a powerful independent predictor of death or heart failure (HF) when measured at admission in patients with chest pain or acute coronary syndrome. Little is known about the role of NT-proBNP level measured during a hospitalization for ST segment elevation myocardial infarction (STEMI) in predicting clinical outcomes. We evaluated the optimal NT-proBNP timing (admission, 72 hours, or delta [Δ] NT-proBNP [72 hours minus admission]) to predict 1-year new-onset HF in STEMI patients.METHODS: We measured NT-proBNP levels at admission and 72 hours in 72 patients with STEMI. HF events were adjudicated and defined as hospitalization for HF or need for new initiation of a loop diuretic at 1-year follow-up. Values are presented as medians and interquartile range or frequencies (%) as appropriate. Cox regression analysis was used to determine predictors of adverse events. A receiver-operative-curve was constructed to identify the discriminative value and optimal cut-off points for NT-proBNP.RESULTS: Patients (age 56 [49-64] years, males 59 [82%]) were followed for a median duration of 365 [180-365] days. HF events were recorded in 9 (12.5%) patients. NT-proBNP values at admission, 72 hours, and ΔNT-proBNP were 89 (26-268) pg/mL, 452 (223-1064) pg/mL, and 283 (68-686) pg/mL, respectively. NT-proBNP at 72 hours and ΔNT-proBNP, but not admission NT-proBNP predicted new-onset HF events at follow-up (P=0.03, P=0.002 and P=0.89, respectively). The optimal area under the curve of 0.771 (95%, CI [0.630-0.912], P= 0.009) and cut-off value of 830 pg/mL (sensitivity 79%; specificity 76%) were found for NT-proBNP at 72 hours. The Kaplan-Meier survival curves for NT-proBNP at 72 hours dichotomized above and below this cut-off value, confirmed NT-proBNP at 72 hours >830 pg/mL as predictive of HF events (log-rank statistic = 8.688, P=0.003).CONCLUSIONS: NT-proBNP level at 72 hours and ΔNT-proBNP (72 hours minus admission), but not at time of admission, predicted HF events in patients following STEMI.
No takes yet. Share an insight, caveat, or question.
Canada et al. (2022) conducted a cohort in ST segment elevation myocardial infarction (STEMI) (n=72). NT-proBNP at 72 hours and ΔNT-proBNP vs. NT-proBNP at admission was evaluated on New-onset heart failure at 1 year (AUC 0.771, 95% CI 0.630-0.912, p=0.009). NT-proBNP levels at 72 hours >830 pg/mL predicted 1-year new-onset heart failure in patients with STEMI (AUC 0.771; 95% CI 0.630-0.912; P=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: